Cargando…

Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome

OBJECTIVE: Reducing levels of the microtubule-associated protein tau has shown promise as a potential treatment strategy for diseases with secondary epileptic features such as Alzheimer disease. We wanted to determine whether tau reduction may also be of benefit in intractable genetic epilepsies. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gheyara, Ania L, Ponnusamy, Ravikumar, Djukic, Biljana, Craft, Ryan J, Ho, Kaitlyn, Guo, Weikun, Finucane, Mariel M, Sanchez, Pascal E, Mucke, Lennart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338764/ https://www.ncbi.nlm.nih.gov/pubmed/25042160 http://dx.doi.org/10.1002/ana.24230

Ejemplares similares

Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
por: Maeda, Sumihiro, et al.
Publicado: (2016)

Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice
por: Cheng, Jason S., et al.
Publicado: (2014)

Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
por: Miyamoto, Takashi, et al.
Publicado: (2017)

DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
por: Suberbielle, Elsa, et al.
Publicado: (2015)

Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011)

Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
por: Vossel, Keith A., et al.
Publicado: (2015)

Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
por: Harris, Julie A., et al.
Publicado: (2012)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
por: Meador, Kimford J.
Publicado: (2014)

Dravet syndrome
por: Incorpora, Gemma
Publicado: (2009)

Disordered breathing in a mouse model of Dravet syndrome
por: Kuo, Fu-Shan, et al.
Publicado: (2019)

Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1
por: Johnson, Erik C. B., et al.
Publicado: (2020)

Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation/inhibition ratios, and counteracts network hypersynchrony
por: Chang, Che-Wei, et al.
Publicado: (2021)

Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome
por: Mattis, Joanna, et al.
Publicado: (2022)

Vaccinations and Dravet Syndrome
por: Korff, Christian M.
Publicado: (2015)

Phenotypes of Dravet Syndrome
por: Garcia-Sosa, Rebecca, et al.
Publicado: (2016)

Dravet Syndrome: An Overview
por: Anwar, Arsalan, et al.
Publicado: (2019)

Stiripentol for Dravet syndrome
Publicado: (2020)

Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome
por: Martín-Suárez, Soraya, et al.
Publicado: (2020)

Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
por: Ho, Shih-Yin, et al.
Publicado: (2021)

Ictal vocalizations in the Scn1a (+/−) mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2023)

Crouch Gait in Dravet Syndrome
por: Black, Laura, et al.
Publicado: (2016)

Anesthetic considerations in Dravet syndrome
por: Macdonald‐Laurs, Emma, et al.
Publicado: (2022)

Open the Window for the Cure of Dravet
por: Gu, Bin
Publicado: (2022)

Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model
por: Salazar, Juan J., et al.
Publicado: (2023)

Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome
por: Wong, Jennifer C., et al.
Publicado: (2019)

512 Odorant exposure decreases mortality in a Dravet Syndrome mouse model
por: Nobis, William, et al.
Publicado: (2023)

Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome
por: Hameed, Mustafa Q., et al.
Publicado: (2023)

Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes
por: Ding, Jiangwei, et al.
Publicado: (2022)

Fatal Status Epilepticus in Dravet Syndrome
por: De Liso, Paola, et al.
Publicado: (2020)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome
por: Goff, Kevin M, et al.
Publicado: (2019)

Combined Antiseizure Efficacy of Cannabidiol and Clonazepam in a Conditional Mouse Model of Dravet Syndrome
por: Chuang, Shu-Hui, et al.
Publicado: (2021)

Incidence of Dravet Syndrome in a US Population
por: Krueger, Jena, et al.
Publicado: (2015)

Audit of use of stiripentol in adults with Dravet syndrome
por: Balestrini, S., et al.
Publicado: (2016)

Dravet Syndrome: A Developmental and Epileptic Encephalopathy
por: Lopez-Santiago, Luis, et al.
Publicado: (2019)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Dravet Syndrome—The Polish Family’s Perspective Study
por: Paprocka, Justyna, et al.
Publicado: (2021)

Patient with Dravet syndrome: A case report
por: Yadav, Rukesh, et al.
Publicado: (2022)

International consensus on diagnosis and management of Dravet syndrome
por: Wirrell, Elaine C., et al.
Publicado: (2022)

A registry for Dravet syndrome: The Italian experience
por: Balestrini, Simona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_chju1d2jvn2elr1b1g6nf4kd58